New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of Sciences, Philadelphia, USA.
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D005128:Eye Diseases / Q000188:drug therapy / Q000209:etiology; D005477:Fluprednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy / Q000503:physiopathology; D006973:Hypertension / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011725:Pyridines / Q000008:administration & dosage*; D013747:Tetrabenazine / Q000008:administration & dosage*
D018759:Adrenergic Uptake Inhibitors; D000959:Antihypertensive Agents; D005938:Glucocorticoids; D011725:Pyridines; C118563:clevidipine; D005477:Fluprednisolone; C015808:difluprednate; D013747:Tetrabenazine